Profile picture

Doctor Daniela Di Lisi

University Hospital Paolo Giaccone, Palermo (Italy)
Membership: ESC Professional Member EACVI Member
Follow
Biography
I am a specialist in cardiovascular diseases, graduated in medicine in 2010 at University of Palermo and specialized in Cardiovascular Diseases, in 2016, at University Hospital “Paolo Giaccone” of Palermo. I am a member of several scientific societies such as Italian Society of Cardiology (SIC), European Society of Cardiology (ESC), European Association of Cardiovascular Imaging (EACVI), Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI). My areas of interest are: cardiovascular imaging, clinical cardiology, cardio-oncology and pediatric cardiology.
Logo ESC

Contributor content

Left atrial function and left atrioventricular coupling index in patients with cardiac amyloidosis
Presentation
Left atrial function and left atrioventricular coupling index in patients with cardiac amyloidosis
Cardiovascular issues in female patients receiving hormonal therapies / Problematiche cardiovascolari in donne in terapie ormonale
Presentation
Cardiovascular issues in female patients receiving hormonal therapies / Problematiche cardiovascolari in donne in terapie ormonale
Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA/ICOS risk score and other parameters
Presentation
Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA/ICOS risk score and other parameters
Right atrial mass and high degree atrioventricular block:  A transient cause or not?
Presentation
Right atrial mass and high degree atrioventricular block: A transient cause or not?
Left atrial strain and left atrial stiffness for early detection of cardiotoxicity in cancer patients
Presentation
Left atrial strain and left atrial stiffness for early detection of cardiotoxicity in cancer patients
Use of myocardial work for multiparametric detection of subclinical anthracycline cardiotoxicity in breast cancer patients.
Presentation
Use of myocardial work for multiparametric detection of subclinical anthracycline cardiotoxicity in breast cancer patients.

ESC 365 is supported by